131 related articles for article (PubMed ID: 36828805)
41. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
[TBL] [Abstract][Full Text] [Related]
42. Outcome of stem cell transplantation for Waldenström's macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group.
Sakurai M; Mori T; Uchiyama H; Ago H; Iwato K; Eto T; Iwasaki H; Kawata T; Takamatsu H; Yamasaki S; Takanashi M; Ichinohe T; Atsuta Y; Suzuki R
Ann Hematol; 2020 Jul; 99(7):1635-1642. PubMed ID: 32424672
[TBL] [Abstract][Full Text] [Related]
43. Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience.
Nachbaur D; Oberaigner W; Fritsch E; Nussbaumer W; Gastl G
Eur J Haematol; 2001 Jan; 66(1):43-9. PubMed ID: 11168507
[TBL] [Abstract][Full Text] [Related]
44. Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation.
Schnabel B; Schmidmaier R; Franke D; Emmerich B; Straka C
Cytotherapy; 2006; 8(5):473-9. PubMed ID: 17050252
[TBL] [Abstract][Full Text] [Related]
45. Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation.
Peters C; Ladenstein R; Minkov M; Pötschger U; Gadner H; Cornish J; Dini G; Klingebiel T; Locatelli F; Vossen J; Niethammer D
Bone Marrow Transplant; 1998 Sep; 22(5):431-7. PubMed ID: 9733265
[TBL] [Abstract][Full Text] [Related]
46. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.
Dandoy CE; Haslam D; Lane A; Jodele S; Demmel K; El-Bietar J; Flesch L; Myers KC; Pate A; Rotz S; Daniels P; Wallace G; Nelson A; Waters H; Connelly B; Davies SM
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1671-1677. PubMed ID: 27311966
[TBL] [Abstract][Full Text] [Related]
47. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
Ikeda T; Mori K; Kawamura K; Mori T; Hagiwara S; Ueda Y; Kahata K; Uchida N; Tsukada N; Murakami S; Yamamoto M; Takahashi T; Ichinohe T; Onizuka M; Atsuta Y; Kanda Y; Okamoto S; Sunami K; Takamatsu H
Hematol Oncol; 2019 Dec; 37(5):586-594. PubMed ID: 31674032
[TBL] [Abstract][Full Text] [Related]
48. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
Chevallier P; Labopin M; Socie G; Rubio MT; Blaise D; Vigouroux S; Huynh A; Michallet M; Bay JO; Maury S; Yakoub-Agha I; Fegueux N; Deconinck E; Contentin N; Maillard N; Bulabois CE; Francois S; Oumedaly R; Raus N; Mohty M
Eur J Haematol; 2015 May; 94(5):449-55. PubMed ID: 25238651
[TBL] [Abstract][Full Text] [Related]
49. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma.
Herrmann RP; Trent M; Cooney J; Cannell PK
Bone Marrow Transplant; 1999 Dec; 24(11):1213-7. PubMed ID: 10642811
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of pre-transplant circulating CD3
Kim TW; Lee SE; Lim JY; Ryu DB; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27910184
[TBL] [Abstract][Full Text] [Related]
51. Economic analysis of a phase III study of G-CSF vs placebo following allogeneic blood stem cell transplantation.
Stinson TJ; Adams JR; Bishop MR; Kruse S; Tarantolo S; Bennet CL
Bone Marrow Transplant; 2000 Sep; 26(6):663-6. PubMed ID: 11041569
[TBL] [Abstract][Full Text] [Related]
52. Infections diagnosed in the first year after pediatric stem cell transplantation.
Benjamin DK; Miller WC; Bayliff S; Martel L; Alexander KA; Martin PL
Pediatr Infect Dis J; 2002 Mar; 21(3):227-34. PubMed ID: 12005087
[TBL] [Abstract][Full Text] [Related]
53. [Epidemiology of early infections after autologous hematopoietic stem cell transplantation.
Lakatos B; Szabó H; Csordás K; Tatai G; Nikolova R; Csomor J; Reményi P; Masszi T; Vályi-Nagy I; Sinkó J
Orv Hetil; 2020 Jan; 161(3):103-109. PubMed ID: 31928060
[TBL] [Abstract][Full Text] [Related]
54. Clinical-associated characteristics and microbiological features of bloodstream nontyphoidal salmonella infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Ko PS; Liu YC; Wang HY; Wu CY; Fan NW; Liu CJ; Yu YB; Hsiao LT; Chiou TJ; Tzeng CH; Liu JH; Gau JP
Ann Hematol; 2017 Sep; 96(9):1533-1540. PubMed ID: 28710648
[TBL] [Abstract][Full Text] [Related]
55. Severe sepsis in hematopoietic stem cell transplant recipients*.
Kumar G; Ahmad S; Taneja A; Patel J; Guddati AK; Nanchal R;
Crit Care Med; 2015 Feb; 43(2):411-21. PubMed ID: 25599465
[TBL] [Abstract][Full Text] [Related]
56. Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.
Gudiol C; Garcia-Vidal C; Arnan M; Sánchez-Ortega I; Patiño B; Duarte R; Carratalà J
Bone Marrow Transplant; 2014 Jun; 49(6):824-30. PubMed ID: 24662420
[TBL] [Abstract][Full Text] [Related]
57. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
[TBL] [Abstract][Full Text] [Related]
58. Standardized Semistructured Psychosocial Evaluation Before Stem Cell Transplantation Predicts Delirium After Transplant.
Mishkin AD; Schmajuk M; Reshef R; Lopez-Pintado S; Mapara MY; Shapiro PA
J Acad Consult Liaison Psychiatry; 2021; 62(4):440-444. PubMed ID: 34219657
[TBL] [Abstract][Full Text] [Related]
59. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey.
Engelhard D; Cordonnier C; Shaw PJ; Parkalli T; Guenther C; Martino R; Dekker AW; Prentice HG; Gustavsson A; Nurnberger W; Ljungman P;
Br J Haematol; 2002 May; 117(2):444-50. PubMed ID: 11972532
[TBL] [Abstract][Full Text] [Related]
60. Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.
Porter DL; Luger SM; Duffy KM; Stadtmauer EA; Laport G; Schuster SJ; Orloff G; Tsai D; McDaid K; Kathakali A; Leonard DG; Antin JH
Biol Blood Marrow Transplant; 2001; 7(4):230-8. PubMed ID: 11349810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]